Joint Corp. (JYNT)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
11.14
0.01 (0.09%)
At close: Jan 28, 2025, 2:15 PM
Company Description
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics.
The company operates in two segments, Corporate Clinics and Franchise Operations.
It operates through direct ownership, management arrangements, franchising, and regional developers.
As of March 1, 2022, the company operated approximately 700 locations in the United States.
The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Joint Corp.
Country | United States |
IPO Date | Nov 11, 2014 |
Industry | Medical - Care Facilities |
Sector | Healthcare |
Employees | 444 |
CEO | Sanjiv Razdan |
Contact Details
Address: 16767 North Perimeter Drive Scottsdale, Arizona United States | |
Website | https://www.thejoint.com |
Stock Details
Ticker Symbol | JYNT |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001612630 |
CUSIP Number | 47973J102 |
ISIN Number | US47973J1025 |
Employer ID | 90-0544160 |
SIC Code | 6794 |
Key Executives
Name | Position |
---|---|
Sanjiv Razdan | Chief Executive Officer, President & Director |
Charles Nelles | Chief Technology Officer |
Jake Singleton CPA | Chief Financial Officer |
Lori I. Abou Habib | Chief Marketing Officer |
Beth Gross | Senior Vice President of Human Resources |
Craig P. Colmar J.D. | Secretary |
Dr. Steven Knauf | Vice President of Chiropractic & Compliance |
Eric Simon | Senior Vice President of Franchise Sales & Development |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jan 16, 2025 | 8-K | Current Report |
Jan 06, 2025 | SCHEDULE 13D/A | [Amend] Filing |
Dec 23, 2024 | 8-K | Current Report |
Nov 08, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 08, 2024 | 10-Q | Quarterly Report |
Nov 07, 2024 | 8-K | Current Report |
Oct 24, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Oct 16, 2024 | 4 | Filing |
Oct 16, 2024 | 3 | Filing |
Oct 15, 2024 | 8-K | Current Report |